Pharma

Your Article Summary

See Latest Articles

Allos Therapeutics Reports Third Quarter 2009 Financial Results
Allos Therapeutics, 11/04/09

Allos Therapeutics, Inc. reported results for the third quarter of 2009. For the three months ended September 30, 2009, the Company reported a net loss of $18.7 million, or ($0.21) per share. This compares to a net loss of $13.2 million, or ($0.16) per share, for the third quarter of 2008. For the nine months ended September 30, 2009, the Company reported a net loss of $50.6 million, or ($0.58) per share, compared to a net loss of $37.0 million, or ($0.50) per share, for the same period last year.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09

Ultrasound, nuc med on the upswing
Canadian Healthcare Technology, 10/16/09

See All of Financial Reports